The Business Research Company's Hereditary Angioedema Therapeutics Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, August 14, 2024 /EINPresswire.com/ -- The hereditary angioedema therapeutics market has experienced robust growth in recent years, expanding from $5.74 billion in 2023 to $6.76 billion in 2024 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to improved diagnosis and awareness, treatment access expansion, research and development initiatives, patient advocacy and education, and regulatory approvals.

Strong Future Growth Anticipated
The hereditary angioedema therapeutics market is projected to continue its strong growth, reaching $13.47 billion in 2028 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to advancements in targeted therapies, global market expansion, gene therapy developments, personalized medicine trends, and collaboration in research and treatment.

Explore Comprehensive Insights Into The Global Hereditary Angioedema Therapeutics Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=10810&type=smp

Growth Driver Of The Hereditary Angioedema Therapeutics Market
The increasing healthcare expenditure is expected to boost the growth of the hereditary angioedema therapeutics market going forward. Healthcare expenditure refers to the total amount of resources, including financial resources, spent on healthcare goods and services within a specific period in a given geographical area. Greater healthcare expenditure allows for increased investment in research and development activities focused on understanding the underlying causes of hereditary angioedema and developing innovative therapeutic solutions.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report

Major Players And Market Trends
Key players in the hereditary angioedema therapeutics market include Shire PLC, Sanofi S.A., Pharming Healthcare Inc., Attune Pharmaceuticals Inc., Adverum Biotechnologies Inc., Arrowhead Pharmaceuticals Inc.
Major companies operating in the hereditary angioedema therapeutics market are developing bradykinin B2 receptor antagonists to meet larger customer bases, more sales, and increase revenue. A bradykinin B2 receptor antagonist is a type of pharmaceutical agent that blocks or inhibits the activity of the bradykinin B2 receptor.

Segments:
1) By Drug Class: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes
2) By Route of Administration: Intravenous, Subcutaneous, Oral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By Application: Prophylaxis, On-demand

Geographical Insights: North America Leading The Market
North America was the largest region in the global hereditary angioedema therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary angioedema therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Hereditary Angioedema Therapeutics Market Definition
Hereditary angioedema (HAE) therapeutics refers to therapy for an autosomal dominant condition brought on by a deficiency in or malfunction of the C1-inhibitor protein. Hereditary angioedema symptoms include angioedema-related upper airway, cutaneous, and, or gastrointestinal complaints.

Hereditary Angioedema Therapeutics Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Hereditary Angioedema Therapeutics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on hereditary angioedema therapeutics market size, hereditary angioedema therapeutics market drivers and trends, hereditary angioedema therapeutics market major players, hereditary angioedema therapeutics competitors' revenues, hereditary angioedema therapeutics market positioning, and hereditary angioedema therapeutics market growth across geographies. The hereditary angioedema therapeutics market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Cold Pain Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Physical Therapy Software Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/physical-therapy-software-global-market-report

Vitamin D Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube